Trial Profile
A Trial Comparing the Pharmacokinetics of Nonacog Beta Pegol (N9-GP) and ALPROLIX in Patients With Haemophilia B
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 May 2023
Price :
$35
*
At a glance
- Drugs Nonacog beta pegol (Primary) ; Eftrenonacog alfa
- Indications Haemophilia B
- Focus Pharmacokinetics
- Acronyms paradigm 7
- Sponsors Novo Nordisk
- 21 May 2018 Results presented in a Novo Nordisk media release.
- 21 May 2018 Results presented in a Novo Nordisk media release.
- 21 May 2018 According to a Novo Nordisk media release, pharmacokinetic findings were presented today at the WFH 2018 World Congress.